SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Miconazole | 22916-47-8 | sc-204806 sc-204806A | 1 g 5 g | $65.00 $157.00 | 2 | |
Miconazole, an antifungal agent, inhibits cytochrome P450 enzymes, disrupting steroid synthesis. This can affect GPCR function, including olfactory receptors like Olfr945, by altering membrane lipid composition and receptor conformation. | ||||||
Nadolol | 42200-33-9 | sc-253175 | 1 g | $180.00 | ||
Nadolol, a non-selective beta-adrenergic blocker, impacts GPCR-mediated signaling. This can lead to altered G-protein coupling efficiency in receptors like Olfr945, indirectly affecting their olfactory signal transduction. | ||||||
Olanzapine | 132539-06-1 | sc-212469 | 100 mg | $130.00 | 6 | |
Olanzapine, an atypical antipsychotic, acts on various neurotransmitter receptors, including GPCRs. Its broad receptor interaction profile can lead to modulation of GPCR pathways, indirectly affecting Olfr945 activity in olfaction. | ||||||
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $80.00 $326.00 | 1 | |
Ondansetron, a selective serotonin 5-HT3 receptor antagonist, indirectly affects GPCR signaling pathways. Its action on serotonin receptors can influence G-protein coupling in receptors like Olfr945, altering their signal transduction. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $105.00 $238.00 | 3 | |
Metoprolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr945 function. | ||||||
Buprenorphine | 52485-79-7 | sc-507499 | 1 mL | $42.00 | ||
Buprenorphine, a partial opioid receptor antagonist, influences GPCR signaling by blocking opioid receptors. This can lead to changes in GPCR-mediated signaling cascades, potentially affecting receptors like Olfr945. | ||||||
Rabeprazole | 117976-89-3 | sc-204872 sc-204872A | 10 mg 25 mg | $342.00 $608.00 | 2 | |
Rabeprazole, a proton pump inhibitor, can indirectly modulate GPCR activity. By affecting gastric acid secretion, it influences the histamine-mediated modulation of GPCRs, potentially impacting Olfr945 signaling. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $176.00 | ||
Labetalol, a mixed alpha/beta adrenergic antagonist, modulates GPCR signaling pathways. Its action on both alpha and beta receptors can indirectly affect the signaling of GPCRs like Olfr945. | ||||||
Propafenone Hydrochloride | 34183-22-7 | sc-204863 sc-204863A sc-204863B sc-204863C | 1 g 5 g 25 g 100 g | $21.00 $65.00 $194.00 $491.00 | ||
Propafenone, an antiarrhythmic agent, can influence GPCR function due to its beta-blocker properties. This can lead to indirect modulation of GPCR signaling pathways, potentially affecting Olfr945. | ||||||